- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
0455
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Tianda Pharmaceuticals Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.10 HKD
-1.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 4.4% above the Trend Line and sits at 14.5% of its 52-week range. The latest completed week returned -1.0%, after a 12.0% four-week move. The latest news-sentiment score is 42/100.
Setup score
43
out of 100
Latest Close
0.10 HKD
7 Aug 2026
1W Return
-1.0%
latest completed week
4W Return
12.0%
short-term follow-through
12W Return
13.2%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
2.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 42.63% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.0%
Latest completed week; four-week move 12.0%.
Indicator stack
0/78
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.63%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
42/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 4.4% above the Trend Line and sits at 14.5% of its 52-week range. The latest completed week returned -1.0%, after a 12.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.0% over four weeks, 13.2% over 12 weeks, and -39.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.24Latest activity-pressure read.
Pressure change70.4%Four-week change in activity pressure.
Leadership-10.90Latest relative-leadership reading.
RS change43.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment42/100
Weighted news tone is negative across 1 relevant articles.
0 positive · 0 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.1%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2610 weeks finished lower.
Best week+13.3%Week of 24 Jul.
Worst week-20.0%Week of 6 Mar.
Latest week-1.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks5
Modest losses4
Sharp losses6
Recent vol5.9%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split18/26Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -6.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank- / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Drug Manufacturers - Specialty & Generic
4-week rank1 / 50
Group average-0.2%
Trend breadth8.0%
Trend8.0%active weekly trend signals
MD38.0%positive activity pressure
RS18.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis26/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Next-Week ExpectancyNegative 42.63%Next-week expectancy is negative with a 42.63% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment42/100Weighted news tone is negative across 1 relevant articles.
Tianda Pharmaceuticals Narrows Comprehensive Loss Despite Higher Interim Revenue Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.10 HKD | -1.0% | 0.10 HKD | 0.17 HKD | 1.24 | -10.90 | 450.0K | Off |
| 31 Jul 2026 | 0.10 HKD | 2.0% | 0.10 HKD | 0.17 HKD | 1.01 | -11.85 | 536.0K | Off |
| 24 Jul 2026 | 0.10 HKD | 13.3% | 0.10 HKD | 0.18 HKD | 0.81 | -11.38 | 194.0K | Off |
| 17 Jul 2026 | 0.09 HKD | -2.2% | 0.10 HKD | 0.18 HKD | 0.64 | -21.30 | 6.0K | Off |
| 10 Jul 2026 | 0.09 HKD | 2.2% | 0.10 HKD | 0.18 HKD | 0.73 | -19.32 | 76.0K | Off |
| 3 Jul 2026 | 0.09 HKD | 3.4% | 0.10 HKD | 0.18 HKD | 0.88 | -19.08 | 276.0K | Off |
| 26 Jun 2026 | 0.09 HKD | -4.4% | 0.10 HKD | 0.18 HKD | 0.62 | -19.99 | 258.0K | Off |
| 19 Jun 2026 | 0.09 HKD | -9.0% | 0.10 HKD | 0.18 HKD | 0.26 | -21.28 | 126.0K | Off |
| 12 Jun 2026 | 0.10 HKD | 7.5% | 0.10 HKD | 0.18 HKD | -0.01 | -16.91 | 154.0K | Off |
| 5 Jun 2026 | 0.09 HKD | 8.1% | 0.11 HKD | 0.18 HKD | -0.35 | -24.02 | 66.0K | Off |
| 29 May 2026 | 0.09 HKD | -5.5% | 0.11 HKD | 0.18 HKD | -0.27 | -30.94 | 94.0K | Off |
| 22 May 2026 | 0.09 HKD | 0.0% | 0.11 HKD | 0.18 HKD | -0.06 | -28.87 | 0 | Off |
| 15 May 2026 | 0.09 HKD | -2.2% | 0.11 HKD | 0.18 HKD | -0.02 | -30.59 | 114.0K | Off |
| 8 May 2026 | 0.09 HKD | -5.1% | 0.11 HKD | 0.18 HKD | -0.11 | -31.05 | 186.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.